NextPlat (NXPL)
NASDAQ:NXPL
Want to see NXPL full AI Analyst Report?
Top Page
NextPlat
(NASDAQ:NXPL)
Select Model
Select Model
Rating:60Neutral
Price Target:
$7.50
▲(1129.51% Upside)
Action:Reiterated
Date:05/27/26
The score balances weak financial performance (revenue decline, ongoing losses, and cash burn) against improving operational indicators and constructive guidance from the latest earnings call (meaningful margin expansion and narrowing losses). Technicals are supportive with the stock trading above key moving averages, while valuation remains challenged due to negative earnings and no dividend support in the provided data.
Positive Factors
Gross margin expansion
A sustained jump in consolidated gross margin to ~35% reflects meaningful improvement in unit economics driven by higher-margin healthcare and pharmacy contracts. If maintained as new 340B and fulfillment volumes scale, higher gross margins materially improve path to durable profitability and cash generation.
Negative Factors
Declining revenue
A large YoY and sequential revenue decline reduces scale and raises the bar for margins to produce sustainable profits. Even with improved unit margins, persistent top-line contraction can limit operating leverage, strain recurring revenue, and prolong reliance on external capital until growth resumes.
Read all positive and negative factors
Positive Factors
Negative Factors
Gross margin expansion
A sustained jump in consolidated gross margin to ~35% reflects meaningful improvement in unit economics driven by higher-margin healthcare and pharmacy contracts. If maintained as new 340B and fulfillment volumes scale, higher gross margins materially improve path to durable profitability and cash generation.
Read all positive factors
NextPlat (NXPL) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$19.50M
Dividend YieldN/A
Average Volume (3M)307.20K
Price to Earnings (P/E)―
Beta (1Y)0.99
Revenue Growth-20.58%
EPS Growth35.52%
CountryUS
Employees162
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)-4.46
Shares Outstanding2,708,507
10 Day Avg. Volume353,303
30 Day Avg. Volume307,201
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.80
Price to Sales (P/S)0.26
P/FCF Ratio-2.24
Enterprise Value/Market Cap0.53
Enterprise Value/Revenue0.21
Enterprise Value/Gross Profit1.23
Enterprise Value/Ebitda-1.04
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NextPlat Business Overview & Revenue Model
Company Description
NextPlat Corp, together with its subsidiaries, provides mobile satellite services (MSS) solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and Internet of Things (IoT) connectivity services in the United...
How the Company Makes Money
NextPlat primarily makes money through (1) product sales and distribution and (2) service-based revenue tied to its e-commerce/marketplace operations and healthcare segment. Product revenue is generated when the company sells consumer and healthca...
NextPlat Earnings Call Summary
Earnings Call Date:May 14, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 17, 2026
Earnings Call Sentiment Positive
The call communicates a clear and measurable operational turnaround: substantial margin expansion, sharply reduced operating losses, the healthcare segment returning to profitability, growth in higher-margin pharmacy contract revenue, and stabilized e-commerce performance. These positive developments are counterbalanced by meaningful declines in top-line revenue (both YoY and sequential), an ongoing legal matter, prior Nasdaq compliance actions (reverse split) and the potential dilution implied by an ATM facility. On balance, the improvements in profitability, margins, and segment-level performance are material and portrayed as sustainable catalysts for future growth, outweighing the remaining revenue and corporate governance headwinds.Positive Updates
Significant Gross Margin Expansion
Consolidated gross margin expanded to approximately 35% in Q1 2026, up from ~21% in Q1 2025 (+14 percentage points YoY) and up from ~18% in Q4 2025 (+17 percentage points sequential). Consolidated gross profit rose to ~$3.4M (from ~$2.9M YoY, +17.2%).
Negative Updates
Total Revenue Decline YoY and Sequential
Total net revenues were approximately $10M in Q1 2026, down from ~$14M in the prior year period (-~28.6% YoY) and down from ~$13M in Q4 2025 (-~23.1% sequential), reflecting the effects of prior restructuring and shifting revenue mix.
Read all updates
Q1-2026 Updates
Positive
Negative
Significant Gross Margin Expansion
Consolidated gross margin expanded to approximately 35% in Q1 2026, up from ~21% in Q1 2025 (+14 percentage points YoY) and up from ~18% in Q4 2025 (+17 percentage points sequential). Consolidated gross profit rose to ~$3.4M (from ~$2.9M YoY, +17.2%).
Read all positive updates
Company Guidance
Guidance: management expects operational profitability in the latter half of 2026 with meaningful reductions in operating losses in H2 as new higher‑margin 340B and medication‑fulfillment customers ramp (the company signed five new 340B agreements this quarter that require ~90 days to onboard and are expected to contribute in Q3) and a new e‑commerce healthcare site is slated to go live before the end of Q2. Key metrics supporting that guidance: Q1 net revenues ≈ $10.0M (healthcare ≈ $7.0M, e‑commerce ≈ $3.2M; healthcare ≈ 68% of revenue), pharmacy contract revenue ≈ $1.9M (vs $1.6M in Q4’25 and $1.4M year‑ago), average 7,500 prescriptions filled/month to Florida contract facilities, consolidated gross profit ≈ $3.4M and gross margin ≈ 35% (vs ~21% in Q1’25 and ~18% in Q4’25), pharmacy gross margin ≈ 39% (vs ~20% prior year), total operating expenses ≈ $4.5M (salaries ≈ $2.4M), operating loss ≈ $1.1M (improved from ~$2.1M year‑ago and ~$2.8M Q4’25), cash ≈ $11M and working capital ≈ $14M; management also cited nationwide expansion to all 50 states, record IoT/e‑commerce demand across 130+ countries, and an ATM facility in place for optional capital although there are no current plans to access it.NextPlat Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
62
Positive
Cash Flow
24
Negative
| Breakdown | Mar 2026 | Dec 2024 | Mar 2024 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 54.32M | 65.48M | 37.76M | 11.71M | 7.74M |
| Gross Profit | 10.91M | 16.23M | 11.31M | 2.49M | 1.86M |
| EBITDA | -9.86M | -20.15M | -19.68M | -6.71M | -6.29M |
| Net Income | -11.71M | -14.03M | -3.78M | -9.16M | -8.11M |
Balance Sheet | |||||
| Total Assets | 27.46M | 36.48M | 64.47M | 28.64M | 20.57M |
| Cash, Cash Equivalents and Short-Term Investments | 13.71M | 19.96M | 26.31M | 18.89M | 17.27M |
| Total Debt | 1.49M | 2.26M | 3.01M | 1.07M | 365.22K |
| Total Liabilities | 10.04M | 9.68M | 16.38M | 2.87M | 3.03M |
| Stockholders Equity | 17.31M | 26.68M | 32.18M | 25.78M | 17.53M |
Cash Flow | |||||
| Free Cash Flow | -6.20M | -5.65M | -4.24M | -4.32M | -4.32M |
| Operating Cash Flow | -6.13M | -5.46M | -3.60M | -3.60M | -4.09M |
| Investing Cash Flow | 163.00K | -953.00K | 5.20M | -7.72M | -229.31K |
| Financing Cash Flow | -225.00K | 72.00K | 5.86M | 13.01M | 20.82M |
NextPlat Technical Analysis
Positive
0.61
Price Trends
5.79
Positive
5.80
Positive
6.53
Positive
Market Momentum
0.23
Negative
62.94
Neutral
77.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NXPL, the sentiment is Positive. The current price of 0.61 is below the 20-day moving average (MA) of 6.47, below the 50-day MA of 5.79, and below the 200-day MA of 6.53, indicating a bullish trend. The MACD of 0.23 indicates Negative momentum. The RSI at 62.94 is Neutral, neither overbought nor oversold. The STOCH value of 77.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NXPL.
NextPlat Risk Analysis
NextPlat disclosed 29 risk factors in its most recent earnings report. NextPlat reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 1 New Risks
1.
We are currently listed on The Nasdaq Capital Market. If we are unable to maintain listing of our securities on Nasdaq or any stock exchange, our stock price could be adversely affected and the liquidity of our stock and our ability to obtain financing could be impaired and it may be more difficult for our shareholders to sell their securities. Q1, 2026
NextPlat Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | $19.50M | -1.57 | -37.97% | ― | -20.58% | 35.52% | |
57 Neutral | $17.57M | -2.28 | ― | ― | ― | ― | |
48 Neutral | $11.98M | ― | -106.67% | ― | -34.19% | 40.60% | |
48 Neutral | $177.86M | -1.71 | -195.02% | ― | 43.04% | 59.79% | |
42 Neutral | $16.11M | -1.54 | -174.91% | ― | -2.94% | -614.49% |
* Technology Sector Average
NXPL
NextPlat
6.96
0.37
5.65%
IPM
Intelligent Protection Management
1.95
-0.18
-8.45%
CXAI
CXApp
0.21
-0.79
-79.15%
RYDE
Ryde Group Limited Class A
0.97
0.75
340.64%
WCT
Wellchange Holdings Company Limited
1.45
-12.60
-89.68%
NTCL
NetClass Technology Inc Class A
0.99
-2.44
-71.20%
NextPlat Corporate Events
Business Operations and StrategyFinancial Disclosures
NextPlat Highlights Improving Margins in Turnaround Update
Positive
Apr 29, 2026
On April 29, 2026, NextPlat Corp reported preliminary first-quarter 2026 expectations showing its turnaround plan is gaining traction, with consolidated gross margins projected to exceed 34%, up sharply from about 20% for full-year 2025. Managemen...
Delistings and Listing ChangesRegulatory Filings and Compliance
NextPlat Regains Nasdaq Compliance, Stabilizing Listing Status
Positive
Apr 28, 2026
NextPlat Corp, a global consumer products and services company focused on healthcare and technology solutions delivered via e-commerce and retail channels, also supports businesses in optimizing online sales domestically and abroad. Its operations...
Financial DisclosuresRegulatory Filings and ComplianceStock Split
NextPlat Announces 1-for-10 Reverse Stock Split Implementation
Neutral
Apr 6, 2026
On April 2, 2026, NextPlat Corp filed an amended and restated certificate of incorporation in Nevada to implement a 1-for-10 reverse stock split of its common stock, effective at 12:01 a.m. Eastern Time on April 13, 2026. As a result, every 10 iss...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.